Evidence map›Paper›PMID 37446652›Full record

ReviewMolecules (Basel, Switzerland)2023

Recent Advances in β-Glucosidase Sequence and Structure Engineering: A Brief Review.

Bei Ouyang, Guoping Wang, Nian Zhang, Jiali Zuo, Yunhong Huang, Xihua Zhao

Open access · goldAbstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
6.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 45 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Pseudoxanthomonas fibrivorans sp. nov. 10HAntonie van Leeuwenhoek · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. β-Glucosidase Activity ofFoods (Basel, Switzerland) · 2025
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Bei OuyangCollege of Life Science, Jiangxi Normal University, Nanchang 330022, China.ORCID 0009-0008-7914-1194
Guoping WangCollege of Life Science, Jiangxi Normal University, Nanchang 330022, China.
Nian ZhangCollege of Life Science, Jiangxi Normal University, Nanchang 330022, China.
Jiali ZuoSchool of Computer and Information Engineering, Jiangxi Normal University, Nanchang 330022, China.
Yunhong HuangCollege of Life Science, Jiangxi Normal University, Nanchang 330022, China.
Xihua ZhaoCollege of Life Science, Jiangxi Normal University, Nanchang 330022, China.ORCID 0000-0001-9749-848X
Jiangxi Normal University · CN

Funding

the Doctoral Starting up Foundation of Jiangxi Normal University 5451the National Natural Science Foundation of China 22068014,21666010
6 · The paper itself

Abstract

β-glucosidases (BGLs) play a crucial role in the degradation of lignocellulosic biomass as well as in industrial applications such as pharmaceuticals, foods, and flavors. However, the application of BGLs has been largely hindered by issues such as low enzyme activity, product inhibition, low stability, etc. Many approaches have been developed to engineer BGLs to improve these enzymatic characteristics to facilitate industrial production. In this article, we review the recent advances in BGL engineering in the field, including the efforts from our laboratory. We summarize and discuss the BGL engineering studies according to the targeted functions as well as the specific strategies used for BGL engineering.

Indexed as

beta-Glucosidasebeta-Glucosidasebiocatalysisbiosynthesisenzyme engineeringβ-glucosidase

Identifiers

PMID37446652
PMCPMC10343665
OpenAlexW4382060579

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.